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Introduction
Urinary tract infections (UTIs) remain among the most common infectious disease worldwide (1). It 
is frequent in women and children and is a particular problem for patients with diabetes, renal trans-
plants, and catheterization (2–4). UTIs present as a wide spectrum of  diseases, including bladder infec-
tion (cystitis), kidney infection (pyelonephritis), and kidney-infection-related complications such as 
renal scarring and sepsis. The causative organisms are usually uropathogenic strains of  E. coli (UPEC). 
Despite antimicrobial therapy, the treatment of  UTI remains a challenge for dealing with frequent 
recurrence or persistence of  infection. Coupled with an increase in antibiotic resistance, even for organ-
isms of  confirmed antibiotic sensitivity (5, 6), this highlights a need to improve our understanding of  
the pathogenic mechanisms underlying this disease, in order to develop novel treatment strategies and 
improve current treatments.
Acute pyelonephritis (APN) resulting from bacterial infection of  the renal parenchyma is an acute 
and severe kidney infection. The pathogenesis of  APN can be influenced by the virulence of  the infect-
ing pathogens, the host-pathogen interaction, and host responses to pathogens, in addition to other 
factors such as urinary obstruction (7, 8). Most UPEC express a variety of  fimbriae (e.g., P, Dr, and 
type 1) that contain lectins that enable them to bind to carbohydrate structures in glycoproteins and gly-
colipids on renal tract epithelial cells, which is a critical step in colonization (9). It has been suggested 
that P fimbriae recognize specific glycolipids [e.g., α-D-Gal-(1,4)-β-D-Gal] on the luminal surface of  
renal tubular epithelium and interact with Toll-like receptor 4 (TLR4), which elicits local inflammatory 
responses that promote tissue destruction and is associated with APN (10). In contrast to P fimbriae, 
C5a receptor 1 (C5aR1) is a G protein–coupled receptor for C5a and also an N-linked glycosylated 
protein. In addition to myeloid cells, C5aR1 is expressed on epithelial cells. In this study, we 
examined the role of C5aR1 in bacterial adhesion/colonization of renal tubular epithelium and 
addressed the underlying mechanisms of this role. We show that acute kidney infection was 
significantly reduced in mice with genetic deletion or through pharmacologic inhibition of C5aR1 
following bladder inoculation with uropathogenic E. coli (UPEC). This was associated with reduced 
expression of terminal α-mannosyl residues (Man; a ligand for type 1 fimbriae of E. coli) on the 
luminal surface of renal tubular epithelium and reduction of early UPEC colonization in these mice. 
Confocal microscopy demonstrated that UPEC bind to Man on the luminal surface of renal tubular 
epithelium. In vitro analyses showed that C5a stimulation enhances Man expression in renal tubular 
epithelial cells and subsequent bacterial adhesion, which, at least in part, is dependent on TNF-α 
driven by C5aR1-mediated intracellular signaling. Our findings demonstrate a previously unknown 
pathogenic role for C5aR1 in acute pyelonephritis, proposing a potentially novel mechanism by 
which C5a/C5aR1 signaling mediates upregulation of carbohydrate ligands on renal tubules to 
facilitate UPEC adhesion.
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Dr fimbriae recognize the receptors (e.g., CD55) located on peritubular basement membranes adjacent 
to the interstitium. This interaction does not cause significant tissue destruction, but is associated with 
chronic pyelonephritis (CPN) (11). Type 1 fimbriae are expressed on most UPEC strains and they 
recognize glycoproteins (e.g., mannosylated glycoproteins) on urinary tract epithelium. It has been sug-
gested that type 1 fimbriae are essential for UPEC adhesion and colonization, thereby contributing 
to the development of  UTI, particularly cystitis (12). Upon contact with epithelial cells, UPEC liber-
ate toxins that mediate direct cellular injury, disrupting the mucosal barrier and providing access to 
the underlying tissue (13, 14). UPEC colonization and entry into underlying tissue can initiate innate 
immune responses, such as direct microbial killing by complement activation and microbial elimination 
by inflammatory cells. However, most human UPEC strains are resistant to complement-mediated kill-
ing (15, 16), and several lines of  study have suggested that these bacteria mediate excessive inflamma-
tory responses that cause epithelial destruction (17–19), impair innate immune cell function, and lead 
to persistent infection and renal fibrosis (20).
C5a is generated by the cleavage of  complement component C5. C5a/C5aR1 interaction mediates 
a broad spectrum of  proinflammatory reactions such as increased vascular permeability, recruitment of  
leukocytes to sites of  injury or infection, generation of  cytotoxic oxygen radicals (by granulocytes), and 
the production of  proinflammatory mediators (21). A large body of  research has demonstrated that C5a/
C5aR1 signaling contributes to the pathogenesis of  a wide range of  inflammatory and immunological dis-
eases (22, 23), but its participation in infectious disease is less known.
Our recent work in a murine model of  CPN has shown that C5a/C5aR1 interactions play an important 
role in the pathogenesis of  chronic renal inflammation and tubulointerstitial fibrosis (20). However, the role 
of  C5aR1 in APN is presently unknown. Such information will improve our understanding of  pathogenic 
roles of  C5aR1 in ascending UTI and help to develop novel therapeutic strategies for improving treatment 
of  acute UTI.
Bacterial–host cell carbohydrate interactions are known to facilitate tissue invasion. Terminal 
α-mannosyl residues (Man) are the carbohydrate ligand for type 1 fimbriae on UPEC (24, 25). Puta-
tive membrane proteins containing such ligands have been reported in the bladder (26). However, it is 
unknown whether such carbohydrate ligands are present within the kidney and whether they play a sig-
nificant role in the development of  pyelonephritis. Given that proinflammatory mediators have been sug-
gested to play a role in regulation of  cell surface mannosylated glycan expression (27), and that C5aR1 
signaling regulates multiple cellular responses, we hypothesized that C5a/C5aR1 interactions mediate 
upregulation of  carbohydrate ligands on renal tubules to facilitate UPEC adhesion/colonization that 
increases susceptibility to APN.
To address this, we employed a well-established murine model of  APN, which is induced by bladder 
inoculation with human UPEC strain J96 (19, 28, 29). We applied this model to both wild-type (WT) and 
C5aR1-deficient mice (C5aR1–/–) to determine the pathogenic roles of  C5aR1 in acute kidney infection. We 
performed a series of  ex vivo (renal tissue) and in vitro (primary cultures of  renal tubular epithelial cells 
[RTECs]) experiments to assess the impact of  C5aR1 on Man expression and UPEC adhesion/coloniza-
tion of  renal tubular epithelium and RTECs. Bone marrow–chimera experiments were performed to evalu-
ate the relative contributions of  C5aR1 expressed on renal parenchyma or myeloid cells to the etiology of  
APN. C5aR1 antagonist (PMX53) was used to assess the therapeutic potential of  targeting C5aR1 in our 
UTI model. Our data demonstrate a previously unknown pathogenic role for C5aR1 in APN and suggest a 
potentially novel mechanism by which C5aR1 mediates enhancement of  Man-dependent bacterial coloni-
zation of  renal tubular epithelium increasing susceptibility to ascending UTI.
Results
C5aR1 deficiency protects mice from APN. Although the expression of  C5aR1 in the kidney has been previously 
reported (30, 31), distribution within the kidney has not been well documented. Therefore, we thoroughly 
examined the expression of  C5aR1 in murine kidney. Our expression studies confirmed the presence of  
C5aR1 on the luminal surface of  renal tubule cells with concomitant increase of  C5aR1 mRNA expression 
in the kidney at 6 and 24 hours postinoculation (hpi) (Figure 1, A and B). C5a expression was detected in 
renal tissues and urine samples under normal conditions, which was elevated at 6 and 24 hpi (Figure 1, 
C and D). Thus, abundant expression of  C5aR1 in renal tubular cells, upregulation of  intrarenal C5aR1 
expression, and elevation of  C5a levels following infection support an involvement of  C5a/C5aR1 in UTIs.
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To determine the role of  C5aR1 in APN, we induced the infection in WT and C5aR1–/– mice, and then 
assessed renal bacterial load and tissue destruction up to 72 hpi. C5aR1–/– mice had significantly lower 
bacterial loads in the kidney at all time points (24, 48, and 72 hpi) (Figure 2A). Renal histopathologi-
cal changes (i.e., cellular infiltration, bacterial patchiness, tubule destruction) within the cortical-medullar 
junction and the medulla were assessed as previously described (19). C5aR1–/– mice displayed less severe 
renal histological lesions (72 hpi) when compared with WT controls (Figure 2, B and C). We also assessed 
tissue inflammation at early time points of  postinoculation (6 hpi). Semiquantitative reverse transcription 
PCR (RT-qPCR) analysis revealed that intrarenal gene expression of  key inflammatory mediators (i.e., 
TNFA, CCL2, CXCL1, CXCL2) were significantly reduced in C5aR1–/– mice compared with WT controls 
(Figure 2D). Flow cytometric analysis showed that C5aR1–/– mice had significantly fewer infiltrating leuko-
cytes (i.e., total leukocytes, neutrophils, monocytes/macrophages [MO/MΦ], inflammatory monocytes) 
in the kidney, compared with WT controls (24 hpi) (Figure 2E and Supplemental Figure 1; supplemental 
material available online with this article; https://doi.org/10.1172/jci.insight.97626DS1).
Collectively, these data demonstrate that acute kidney infection was significantly reduced in C5aR1–/– 
mice, supporting a pathogenic role for C5aR1 in the development of  APN.
C5aR1 is required for Man expression in renal tubules and bacterial colonization of  renal tract epithelium. We first 
determined the expression of  glycans within the kidney and its association with C5aR1 status, by performing 
lectin staining in both normal and infected kidneys. We employed 3 fluorescein-labeled lectin probes: Galan-
thus nivalis lectin (GNL, which binds to [α-1,3]Man); Lens culinaris agglutinin (LCA, which binds to branched 
fucose/mannose residues); and Sambucus nigra bark lectin (SNA, which binds to sialic acid attached to termi-
nal galactose). These 3 lectins have been used for the detection of  high-mannose, hybrid, and complex N-gly-
cans, respectively. GNL staining clearly showed the presence of  Man in normal kidneys, which was located 
mainly within the cortical and medullary tubules, with predominant expression on the luminal surface of  
Figure 1. Detection of C5a and C5aR1 in urinary tract. (A) C5aR1 expression in WT kidney tissue determined by immunochemistry. Kidney tissue from 
C5aR1–/– mice was used as a negative control. Scale bars: 250 μm. Boxed regions correspond to the next (right) image (scale bars: 50 μm and 10 μm, respec-
tively). Arrows indicate positive C5aR1 staining. A representative of 3 experiments is shown. (B) Relative mRNA levels of C5aR1 in normal and infected kid-
ney tissues determined by RT-qPCR (n = 6 normal, n = 7–10 infected). (C and D) C5a levels in kidney tissue and urine samples determined by ELISA (n = 5–7 
normal, n = 7–12 infected). (B–D) Each data point represents an individual mouse. Data were analyzed by 1-way ANOVA with Tukey’s multiple comparisons 
test. *P < 0.05, **P < 0.005, ***P < 0.001.
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Figure 2. C5aR1 deficiency protects mice 
from acute pyelonephritis. (A) Bacterial 
loads in kidney tissues of WT and C5aR1–/– 
mice at 24, 48, and 72 hours postinfection 
(hpi) determined by bacterial plate count 
assay (n = 10/group). (B) Representative 
images of PAS staining of kidney sections 
of WT and C5aR1–/– mice at 72 hpi. Top 
panel: Cross-sections of the whole kidney. 
Scale bars: 1,000 μm. Middle and lower 
panels: Higher magnification images 
corresponding to the boxed regions in 
the above panel. Scale bars: 250 μm. (C) 
Histological scores of kidney sections of 
WT and C5aR1–/– mice at 72 hpi (n = 8/
group). (D) Relative mRNA levels of proin-
flammatory mediators in infected kidney 
tissues of WT and C5aR1–/– mice at 6 hpi 
determined by RT-qPCR (n = 8/group). The 
dotted line across each graph represents 
the gene expression level of normal 
kidney tissue, which is similar between 
WT and C5aR1–/– mice. (E) Quantification 
of inflammatory cells in infected kidney 
tissues of WT and C5aR1–/– mice at 24 
hpi. The dotted line across each graph rep-
resents the levels of inflammatory cells 
in normal kidney tissue, which is similar 
between WT and C5aR1–/– mice. MO/MΦ, 
monocytes/macrophages. For all data, 
each data point represents an individual 
mouse. Mann-Whitney test was used 
for CFU data in A. Unpaired 2-tailed Stu-
dent’s t test was used for the data in B–E. 
*P < 0.05, **P < 0.005, ***P < 0.001.
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tubular epithelial cells (Supplemental Figure 2). Interestingly, GNL staining was significantly reduced in 
renal tubules of  C5aR1–/– kidneys when compared with WT controls, including both infected (6 hpi) and 
noninfected kidneys (Figure 3, A and B). However, LCA and SNA staining was predominantly localized to 
the basolateral surface of  renal tubules, with no significant difference observed between WT and C5aR1–/– 
kidneys following UPEC inoculation (Supplemental Figure 3). These observations demonstrate that Man, 
the carbohydrate ligands for type 1 fimbriae, are present within the kidney, and absence of  C5aR1 is specifi-
cally associated with a reduction of  Man expression on the luminal surface of  renal tubules.
We then determined whether the reduced Man expression is associated with UPEC colonization of  
renal tract epithelium. Fluorescence microscopy and bacterial plate count assay revealed that bacterial 
colonies either in the tubular epithelium or the kidney homogenate were significantly reduced in C5aR1–/– 
mice (6 hpi), compared with WT mice (Figure 3, C–E), suggesting that bacterial adhesion/colonization 
of  the renal tract epithelium is C5aR1 dependent. In addition to the J96 strain, we also observed C5aR1-
dependent bacterial colonization in other human pyelonephritis strains: IH11128 (lack of  P fimbriae) and 
CFT073 (data not shown). We also investigated whether UPEC colonize renal epithelium by binding Man 
on renal tubular epithelium. Fluorescence microscopy images revealed colocalization of  bacteria with Man 
on the luminal surface of  renal tubules, indicating Man-dependent UPEC adhesion in the kidney (Figure 
3F). In addition, we examined the spatial relationship between C5aR1 and either Man or bound bacteria in 
renal tubules by immunofluorescence microscopy. Both Man and C5aR1 were predominantly detected on 
the luminal surface of  renal tubules; a colocalization, albeit partial, was observed between C5aR1 and Man 
(Figure 3G). Bacterial colonies were also closely associated with C5aR1 on the luminal surface of  renal 
tubules of  infected kidneys (Figure 3H). Hence, C5aR1 protein is closely associated with Man and bacterial 
adhesion to renal tubules.
Collectively, these findings support a dual requirement of  C5aR1 for Man expression in renal tubules 
and colonization of  renal tract epithelium by UPEC.
C5a stimulation upregulates Man expression and enhances bacterial adhesion/invasion in RTECs. We consid-
ered that C5a/C5aR1 interactions may contribute to the mass of  Man on the luminal surface of  renal 
tubules and promote bacterial adhesion/colonization. How C5a/C5aR1 interactions influence both Man 
expression and bacterial adhesion was examined using primary RTEC cultures. Following C5a and/or 
LPS stimulation of  RTECs, expression of  Man was assessed by fluorescence intensity–based microplate 
and fluorescence microscopy. Results obtained from both assays indicate that C5a or LPS stimulation alone 
increased surface expression of  Man. Combined, C5a/LPS stimulation induced more Man expression 
than C5a treatment alone (Figure 4, A–C). Notably, the stimulatory effect of  C5a on Man expression was 
absent in RTECs from C5aR1–/– mice (Figure 4D), supporting that C5a stimulates Man expression through 
engagement of  C5aR1. Confocal microscopy and bacterial plate count assays revealed that pretreatment of  
RTECs with C5a enhanced bacterial adhesion to RTECs (Figure 4, E–G). The association of  bacteria with 
surface Man on RTECs was shown by confocal Z-stack images (Figure 4H). These observations support the 
concept that C5a/C5aR1 interactions upregulate Man expression in RTECs and facilitate Man-dependent 
UPEC adhesion.
Having demonstrated that C5a has a stimulatory effect on Man expression in RTECs, we sought to 
identify the signal transduction pathways responsible for the action of  C5a. Binding of  C5a to C5aR1 
triggers a variety of  intracellular signaling pathways including cAMP, ERK1/2, and NF-κB, and mediates 
a number of  cellular processes in different types of  cells (32–34); however, little is known in RTECs. In 
addition, activation of  inflammatory signaling ERK1/2 and NF-κB has been suggested as an important 
mechanism involving the regulation of  surface N-glycans in endothelial cells (27). To investigate whether 
the effect of  C5a/C5aR1 interactions on Man expression in RTECs is dependent on such a mechanism, we 
examined the influence of  C5a on intracellular signaling within RTECs, specifically cAMP/PKA/CREB, 
ERK, and IκB (a catalytic subunit of  NF-κB essential for NF-κB activation). C5a stimulation significantly 
reduced intracellular levels of  cAMP (a pivotal second messenger with a broad range of  antiinflammatory 
activities) in RTECs, which was more pronounced by pretreatment of  RTECs with forskolin (a cAMP ele-
vating agent) (Figure 5A). Accordingly, the phosphorylation of  PKA and CREB (the downstream signaling 
of  cAMP) in RTECs was reduced by C5a stimulation (Supplemental Figure 4). By contrast with cAMP/
PKA/CREB, the phosphorylation of  ERK and IκB (which plays a critical role in mediating proinflam-
matory responses) was increased by C5a stimulation (Figure 5B). In addition, we examined the effects of  
C5a on TNF-α production in RTECs. RT-qPCR and ELISA results showed that in the presence of  LPS, 
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Figure 3. C5aR1 is required for mannosyl residue expres-
sion in renal tubules and bacterial colonization of renal 
tract epithelium (in vivo). (A) Representative images of 
mannosyl residue (Man) expression detected by fluoresce-
in-labeled Galanthus nivalis lectin (GNL) (green) in kidney 
sections of WT and C5aR1–/– mice (i.e., noninfected and 
infected with J96 for 6 hours). Scale bars: 100 μm. (B) Quan-
tification of Man expression in renal tubules corresponding 
to the WT and C5aR1–/– mice in A. Data were analyzed by 
1-way ANOVA with Tukey’s multiple comparisons test (n 
= 9 viewing fields from 3 [normal] or 4 [infected] mice/
group). ***P < 0.001. (C) Representative fluorescence 
microscopy images of kidney sections of WT and C5aR1–/– 
mice at 6 hours postinoculation (hpi) of TRITC-labeled J96 
(red), proximal tubular marker (L-fucose) detected by Lotus 
tetragonolobus lectin (LTL) (green), and nuclear marker 
DAPI (blue) are shown, demonstrating early bacterial 
colonization of renal tubular epithelium. Boxed regions 
correspond to the bottom images. Arrows indicate bacte-
rial colonies. Scale bars: 50 μm (top) and 25 μm (bottom). 
(D) Quantification of bacterial colonies in renal tabular 
epithelium corresponding to the WT and C5aR1–/– mice 
in C. Data were analyzed by unpaired 2-tailed Student’s t 
test (n = 60 viewing fields from 8 mice/group, under ×200 
magnification). ***P < 0.001. (E) Bacterial loads in kidney 
tissues corresponding to the WT and C5aR1–/– mice in C 
were also determined by bacterial plate count assay. Data 
were analyzed by Mann-Whitney test. **P < 0.01. In A–E, a 
representative of 2 experiments is shown. (F) Fluorescence 
microscopy images of binding of bacteria (red) to Man 
(green) at the luminal surface of renal tubular epithelium of 
WT mice following the inoculation of TRITC-labeled J96 (6 
hpi). Scale bars: 10 μm. (G) Fluorescence microscopy images 
demonstrating the colocalization of C5aR1 (red) and Man 
(green) in renal tubules of WT mice. Scale bars: 20 μm. (H) 
C5aR1 immunofluorescence microscopy images of the renal 
tubule of WT mice at 6 hpi of TRITC-labeled J96, demon-
strating the association of C5aR1 (green) and bacteria (red) 
in renal tubular epithelial cells. Scale bars: 10 μm. (F–H) A 
representative of 3 experiments is shown.
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Figure 4. C5a stimulation upregulates mannosyl residue expres-
sion and enhances bacterial adhesion in renal tubular epithelial 
cells (in vitro). (A) Effect of C5a and/or LPS stimulation (for 24 
hours) on mannosyl residue (Man) expression in primary cultured 
renal tubular epithelial cells (RTECs) was examined by fluores-
cence intensity–based microplate assay. Data were analyzed 
by 1-way ANOVA with Tukey’s multiple comparisons test (n = 5 
individual wells). **P < 0.005, ***P < 0.001. (B) Representative 
fluorescence images of Man expression in control or C5a and/or 
LPS pretreated RTECs (nonpermeabilized). Man (green) detected 
by fluorescein-labeled Galanthus nivalis lectin (GNL) and DAPI 
(blue) are shown. Scale bars: 25 μm. (C) Quantification of Man 
expression corresponding to the images shown in B. Data were 
analyzed by 1-way ANOVA with Tukey’s multiple comparisons test 
(n = 8 coverslips per group, under ×630 magnification). *P < 0.05, 
***P < 0.001. Data shown are pooled from 4 individual experi-
ments. (D) Quantification of Man expression in RTECs prepared 
from C5aR1–/– mice assessed by fluorescence microscopic analysis 
following C5a stimulation (n = 6 coverslips per group, under 
×630 magnification). Data shown are pooled from 3 individual 
experiments. (E) Representative fluorescence images of bacterial 
adhesion to RTECs that had been pretreated with or without C5a 
for 24 hours, then incubated with TRITC-labeled J96 (1 × 107/well) 
for 1 hour. E. coli (red), Man (green), and DAPI (blue) are shown. 
Scale bars: 25 μm. (F) Quantification of bacteria corresponding to 
the images shown in E. Data shown are from 8 individual images 
(under ×630 magnification, from 3 coverslips) per group and rep-
resentative of 3 independent experiments. ***P < 0.001, analyzed 
by unpaired 2-tailed Student’s t test. (G) Bacterial adhesion to 
RTECs evaluated by CFU assay. Data were analyzed by 2-way 
ANOVA (n = 8 individual wells and representative of 3 indepen-
dent experiments). ***P < 0.001. (H) Confocal microscopic images 
of bound bacteria in RTECs (nonpermeabilized) that had been 
incubated with labeled J96 for 1 hour. Bacteria (red), Man (green), 
and DAPI (blue) are shown. Left image: Compressed image. 
Scale bars: 10 μm. Middle and right images corresponding to the 
boxed regions in the left image show the cross-sectional views 
in Z-stack (bottom and side panel) of RTECs, Man, and bacteria, 
demonstrating association of Man and J96 at the cell surface of 
RTECs. A representative of 3 experiments is shown.
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C5a upregulated both gene expression and the release of  TNF-α by RTECs (Figure 5, C and D). We then 
assessed whether TNF-α is responsible for C5a action on Man upregulation. Addition of  anti–TNF-α anti-
body in RTEC cultures significantly suppressed C5a-mediated upregulation of  Man expression (Figure 5, E 
and F). Taken together, these results led to the suggestion that C5a upregulates Man expression in RTECs, 
at least in part, through the effects of  TNF-α driven by C5aR1-mediated intracellular signaling.
Figure 5. Effects of C5a on intracellular signalling, proinflammatory cytokine production, and mannosyl residue expression in renal tubular epithelial 
cells (in vitro). (A) Renal tubular epithelial cells (RTECs) cultured from WT mice were preincubated with or without forskolin (Fsk, a cAMP elevating agent) 
(10 μM) for 1 hour and stimulated with C5a (0–20 nM) for 30 minutes. Intracellular cAMP levels were measured in the cell lysates, shown as changes relative 
to control (untreated cells). n = 3/group, resulting from 3 independent experiments. **P < 0.005. (B) Western blot analysis for ERK1/2 and IκB phosphory-
lation in RTECs after C5a (20 nM) stimulation for up to 30 minutes. In each set of blots, the top row of bands corresponds to membrane incubated with 
appropriate anti-phospho antibody and the bottom row of bands corresponds to membrane incubated with appropriate total antibody. Relative amounts of 
protein phosphorylation are shown in the right panel of each set of blots. n = 3/group, resulting from 3 independent experiments. (C) Relative mRNA levels 
of TNF-α in the RTECs, determined by RT-qPCR. n = 4/group, resulting from 4 independent experiments. ***P < 0.001. (D) Secretion of TNF-α by the RTECs 
(supernatants from 24-hour cultures), measured by ELISA. n = 3/group, resulting from 3 independent experiments. ***P < 0.001; P = 0.0014 (LPS versus LPS 
plus C5a treatment). (E) Representative images of Man (green) in RTECs that had been pretreated with control Ig, C5a/control Ig, or C5a/anti–TNF-α anti-
body for 24 hours. Scale bars: 25 μm. (F) Quantification of Man expression in RTECs in E. n = 6 coverslips/group, resulting from 3 independent experiments. 
**P < 0.005, ***P < 0.001. Data were analyzed by 1-way ANOVA with Tukey’s multiple comparisons test (A, C, D, and F) or 1-way ANOVA (B).
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Relative contributions of  C5aR1 on parenchymal and infiltrating cells to the development of  APN. To evaluate 
the contribution of  C5aR1 on parenchymal and/or infiltrating cells to the development of  infection, we 
induced UTI in 4 groups of  chimeric mice generated by bone marrow transplantation of  irradiated recipient 
mice (denoted as WT→WT, C5aR1–/–→WT, WT→C5aR1–/–, C5aR1–/–→C5aR1–/–). Attenuated renal bacte-
rial load and tissue damage were observed in mice lacking C5aR1 on recipient renal cells (WT→C5aR1–/–) 
or donor myeloid cells (C5aR1–/–→WT), compared with mice that express C5aR1 on both compartments 
(WT→WT), at 48 hpi. Mice lacking C5aR1 on renal parenchymal cells were afforded better protection, as 
the reduction of  tissue damage and bacterial load was more pronounced in this group of  mice (Figure 6).
Blocking C5aR1 reduces Man expression and bacterial colonization of  renal tubular epithelium, and protects mice 
from APN. To explore the therapeutic potential of  targeting C5aR1 in UTI, we employed PMX53 (a rec-
ognized C5aR1 antagonist) (35) in our APN model. PMX53 treatment significantly reduced both Man 
expression and bacterial colonization in renal tubular epithelium (Figure 7, A–E). A concomitant reduc-
tion in pathological damage, bacterial load, and intrarenal production of  proinflammatory mediators was 
observed in the PMX53-treated mice compared with the control group (Figure 7, F–I). The results were 
consistent with the knockout mouse studies, confirming a role of  C5aR1 in the development of  APN.
Discussion
Our recent work in a murine model of  CPN has demonstrated a pathogenic role for C5aR1 in chronic renal 
inflammation and tubulointerstitial fibrosis and suggested the underlying mechanisms. These mechanisms 
are involved in C5a/C5R1 signaling–mediated upregulation of  intrarenal production of  proinflammatory 
and profibrogenic mediators and impairment of  MΦ killing function, which lead to persistent infection 
and renal scaring (20). The present study focuses on a murine model of  APN. The findings not only dem-
onstrate a previously unknown role for C5aR1 in the pathogenesis of  APN, but also describe a potentially 
novel mechanism by which C5aR1 contributes to ascending UTI. This involves both upregulation of  Man 
expression and promotion of  early bacterial colonization of  renal tubular epithelium, thereby increasing 
susceptibility to ascending UTI.
Man are the well-characterized carbohydrate ligand for FimH of  type 1 fimbriae on E. coli. It has been 
suggested that the interactions of  type 1 fimbriae and mannose-containing host receptors in uroepithelium 
is an important pathogenic mechanism for bladder infection (12, 24, 26). However, the presence and distri-
bution of  such ligands in renal tubular epithelium, binding of  UPECs to ligands within the kidney, and the 
contribution of  the ligands to renal infection are largely unknown. As virtually all clinical UPEC isolates 
express type 1 fimbriae (36), addressing these issues is important for improving our understanding of  the 
pathogenesis of  ascending UTI. In the present study, we clearly show that Man (a known ligand for type 
1 fimbriated UPECs) are expressed within renal tract epithelium and on cultured RTECs. In addition, we 
found that C5aR1 deficiency is associated with reduced levels of  Man expression on the luminal surface of  
renal tract epithelium. Receptor deficiency curtails early bacterial colonization, providing protection from 
ascending UTI. Thus, our data support the argument that C5a/C5aR1–associated upregulation of  Man on 
renal tubules contributes to renal infection through interactions with type 1 fimbriae. In agreement with 
the role of  type 1 fimbriae in renal infection, a previous study has shown that type 1 fimbriae are required 
for UPEC adhesion and colonization in the kidney in vivo (37). In addition to the role of  C5aR1 in kidney 
infection, in separate studies, we have found that C5aR1–/– mice had also reduced bladder infection, in both 
chronic and acute models of  UTI (20) (Wu et al., unpublished observations), suggesting a pathogenic role 
Figure 6. Relative contributions of C5aR1 on parenchymal and infiltrating 
cells to the development of acute pyelonephritis. (A) Histological scores of 
kidney sections of 4 groups of chimeric mice at 48 hours postinfection (hpi). 
(B) Bacterial loads in the kidney tissues corresponding to the 4 groups of 
mice in A. Each data point represents an individual mouse; small horizontal 
lines indicate the mean. All data were analyzed by 1-way ANOVA with Tukey’s 
multiple comparisons test (n = 6 mice/group). *P < 0.05, ***P < 0.001. BM, 
bone marrow; WT, wild-type littermates; –/–, C5aR1–/– mice.
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Figure 7. Blocking C5aR1 reduces 
mannosyl residue expression and 
bacterial colonization of renal 
tubular epithelium, and protects 
mice from acute pyelonephritis. 
(A) A schematic diagram of the 
experimental design. WT mice 
received control or PMX53 (1 mg/kg) 
treatment 2 hours before bacterial 
inoculation and 24 hours after inoc-
ulation. (B) Representative images 
of mannosyl residues (Man) (green) 
in kidney sections of infected WT 
mice that received control or PMX53 
(1 mg/kg) treatment at 6 hours 
postinoculation. Scale bars: 100 μm. 
(C) Quantification of Man expres-
sion in renal tubules corresponding 
to the mice in B. Data were analyzed 
by unpaired 2-tailed Student’s t test 
(n = 12 viewing fields from 4 mice/
group). (D) Representative images 
showing early bacterial colonization 
of renal tubular epithelium in con-
trol or PMX53-treated mice. TRITC-
labeled J96 (red), proximal tubular 
marker (L-fucose) detected by Lotus 
tetragonolobus lectin (LTL) (green), 
and nuclear marker DAPI (blue) are 
shown. Arrows indicate bacterial 
colonies. Scale bars: 30 μm. (E) 
Quantification of bacterial colonies 
in renal epithelium correspond-
ing to control or PMX53-treated 
mice in D. Data were analyzed by 
unpaired 2-tailed Student’s t test 
(n = 60 viewing fields from 6 mice/
group). (F) Representative images 
of PAS staining of kidney sections 
of control or PMX53-treated mice 
at 48 hours postinoculation. Arrows 
indicate the lesions. Scale bars: 250 
μm. (G) Histological scores of kidney 
sections of control or PMX53-
treated mice in F (n = 4 mice/
group). In F and G, a representa-
tive of 2 experiments is shown. (H) 
Bacterial loads in kidney tissues 
of control or PMX53-treated mice 
determined by CFU assay (n = 10 
mice/group). Data shown are pooled 
from 2 individual experiments. (I) 
Intrarenal TNF-α and CXCL1 levels 
in control or PMX53-treated mice 
evaluated by ELISA (n = 6/group). 
(G–I) Each data point represents 
an individual mouse. Data were 
analyzed by Mann-Whitney test (H) 
or unpaired 2-tailed Student’s t test 
(G and I). *P < 0.05, **P < 0.005, 
***P < 0.001.
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for C5aR1 in bladder infection. Given the critical role of  the bladder infection in ascending UTI, C5aR1-
associated bladder infection could potentially contribute to renal infection.
To address the mechanisms that C5aR1 employs to influence Man expression in the renal tract epithe-
lium, we assessed the possibility that C5a/C5aR1 interactions mediate upregulation of  Man expression in 
renal tract epithelium. We detected the expression of  C5aR1 in renal tract epithelium and the presence of  
C5a in both kidney tissue and urine, and C5aR1 and C5a upregulation following infection. Therefore, argu-
ably, it is possible that C5a/C5aR1 interactions occur in renal tract epithelium under normal conditions, 
thereby mediating the tubule cell activation. This in turn leads to an upregulation of  Man expression. Lectin 
staining of  renal tissue demonstrated that absence of  C5aR1 specifically reduced Man expression in both 
noninfected and infected mice, reflecting a requirement for C5a/C5aR1 interactions for Man expression 
in both normal and pathogenic conditions. The notion that C5a/C5aR1 interactions mediate upregulation 
of  Man in renal tubular epithelium was supported by our in vitro findings where C5a stimulation, particu-
larly in the presence of  LPS, upregulated cell surface Man expression and enhanced UPEC adhesion to 
RTECs. Further studies revealed that C5a upregulates Man expression on RTECs, at least in part, through 
an effect of  TNF-α driven by C5aR1-mediated intracellular signaling (downregulation of  cAMP/PKA/
CREB, upregulation of  ERK and NF-κB). In addition to the effects of  C5a/C5aR1 on downstream signal-
ing, we also considered the direct impact of  C5aR1 on bacterial adhesion. Our confocal microscopy revealed 
a large-scale association between C5aR1 and Man on the luminal surface of  the renal tract epithelium. This, 
together with the fact that C5aR1 is an N-linked glycosylated protein, raises the possibility that C5aR1 as 
a Man-containing glycoprotein may function as a carbohydrate ligand for UPECs and mediate type 1 fim-
briae–dependent bacterial adhesion/colonization.
Chimera studies suggested that C5aR1 on renal cells plays a more prominent role in this model because 
an absence of  C5aR1 on renal cells conferred better protection from infection when compared with an 
absence of  C5aR1 on myeloid cells. The contribution of  renal cell C5aR1 in this model may result from 
epithelial C5aR1–dependent UPEC colonization of  renal tract, as discussed earlier. On the other hand, the 
contribution of  inflammatory cell C5aR1 may reflect inflammatory responses driven by C5aR1 signaling, 
which lead to tissue destruction and upregulation of  Man expression in renal tubular epithelium.
Figure 8. Proposed mechanisms by which C5aR1 enhances UPEC colonization of renal tubular epithelium that 
increases susceptibility to acute pyelonephritis. Based on our findings in this study, we propose that (i) engagement 
of C5aR1 with C5a in renal tubular epithelial cells (RTECs) mediates the production of proinflammatory mediators, 
which results in enhancement of mannosyl residue (Man) expression at the luminal surface of renal tubular epithelium 
(possibly resulting from Man on the cell membrane or specific glycosylated proteins, including C5aR1), subsequently 
facilitating type 1 fimbriae–mediated uropathogenic E. coli (UPEC) adhesion. (ii) This process could be reinforced by 
proinflammatory mediators produced by inflammatory cells driven by C5a/C5aR1 signaling (downregulation of cAMP, 
upregulation of ERK and NF-κB). (iii) In addition, C5aR1 on renal tubular epithelium may function as carbohydrate 
ligands for UPEC binding. All these processes contribute to enhancement of UPEC colonization of renal tubular epithe-
lium that increases susceptibility to acute pyelonephritis (APN).
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Chemical blockade of  C5aR1 with the antagonist PMX53 provided protection from APN in this mod-
el. One explanation for this effect could be that targeting C5aR1 on epithelial cells inhibits C5a-mediated 
upregulation of  Man expression and subsequent bacterial adhesion/colonization. Additionally, targeting 
C5aR1 on inflammatory cells would attenuate C5a-mediated proinflammatory responses, consequently 
reducing tissue damage and curtailing upregulation of  Man via proinflammatory mediators in renal epithe-
lium. In agreement with this, the anti-C5 antibody (BB5.1), which prevents the generation of  C5a and C5b-
9, was found to be effective in conferring protection from APN in this model (data not shown). Therefore, 
the effects of  C5aR1 antagonism in this model could be attributed to the blockade of  C5a/C5aR1 interac-
tions on both renal epithelial cells and inflammatory cells.
Based on the findings presented in this study, we propose a potentially novel mechanism by which 
C5aR1 promotes the development of  APN, namely, that C5aR1 mediates enhancement of  bacterial adhe-
sion/colonization of  renal tubular epithelium. This is achieved through the following processes: (a) engage-
ment of  C5aR1 with C5a on RTECs mediates the production of  proinflammatory mediators, which results 
in enhancement of  Man expression on the luminal surface of  the renal tubular epithelium, subsequently 
facilitating type 1 fimbriae–mediated UPEC adhesion; (b) C5a/C5aR1 signaling promotes the secretion of  
proinflammatory mediators by inflammatory cells; and (c) C5aR1 expressed on the renal tubular epithe-
lium functions as a carbohydrate ligand for UPEC binding (Figure 8). Therefore, C5a/C5aR1–mediated 
early inflammatory responses (in response to initial infection) in the kidney facilitate bacterial adhesion/
colonization of  renal tubular epithelium. This results in further amplification of  inflammatory responses, 
consequently causing more tissue damage and UPEC colonization.
In conclusion, the present study is the first to our knowledge to demonstrate a pathogenic role for C5aR1 
in APN and address the underlying mechanisms of C5aR1 promoting the development of APN. Our study 
provides insight into the mechanisms of bacterial–host cell carbohydrate interactions facilitating tissue invasion. 
Furthermore, the findings presented in this study, coupled with the findings of our previous study in CPN, high-
light pathogenic roles for C5aR1 in ascending UTI and opens up a new avenue for therapeutic targeting in UTI.
Methods
Materials. We used the following reagents and materials: monoclonal anti–mouse CD45 (30-F11, APC), 
Ly6G (1A8, PE), Ly6C (HK1.4, PE/Cy7), CD11b (M1/70, FITC) (all BioLegend); polyclonal goat anti–
mouse C5aR1 (M-19) (Santa Cruz Biotechnology); fluorescein-labeled Lotus tetragonolobus lectin (LTL), 
-GNL, -LCA, and -SNA (all Vector Laboratories); polyclonal rabbit anti–mouse cytokeratin (wide spec-
trum) (Abcam); cell culture medium, fetal calf  serum, insulin-transferrin-selenium solution, gentamicin, 
and CountBright absolute counting beads (Life Technologies Ltd); 4′,6-diamidino-2-phenylindole (DAPI) 
(Life Sciences); Alexa Fluor 488 donkey anti–goat IgG (Jackson ImmunoResearch Lab Inc.); FcR-blocking 
antibody (CD16/32, 2.4G2) and mouse ELISA kits for TNF-α and paired ELISA antibodies for C5a (BD 
Biosciences); MPO assay kit and mouse ELISA kit for CXCL1, recombinant mouse TNF-α, monoclonal 
anti–mouse TNF-α (MP6-XT22), and isotype control (43414) (R&D Systems); hydrocortisone, triiodothyro-
nine, thioglycollate, tetramethylrhodamine (TRITC), protease inhibitor cocktail, LPS (from E. coli with sero-
type O55:B5, contains O antigen) (Sigma-Aldrich); collagenase D (Roche); collagenase type II (Worthington 
Biochemical Corp.); C5aR1 peptide antagonist (PMX53, Ac-Phe-cyclo [Orn-Pro-dCha-Trp-Arg]) and con-
trol peptide (random sequence) (synthesized by GenScript).
Mice. Homozygous C5aR1–/– mice were generated by homologous recombination in embryonic stem 
cells (38) (provided by Bao Lu and Craig Gerard, Harvard Medical School, Boston, Massachusetts, USA) 
and backcrossed onto the C57BL/6 (H-2b) parental strain for at least 12 generations. WT littermate mice 
were used as controls. Female mice (8–10 weeks old) were used in all experiments. All mice were main-
tained in specific pathogen–free conditions.
Bacterial strains. E. coli J96 (serotype O4; K6), a human pyelonephritis isolate, was provided by Rodney 
Welch (University of  Wisconsin, Madison, Wisconsin, USA). J96 is a serum-resistant, hemolysin-secreting 
E. coli strain that expresses both type 1 and P fimbriae. Cystitis isolate NU14 and the isogenic fimH-mutant 
NU14-1 were provided by Scott Hultgren (Washington University School of  Medicine, St. Louis, Missouri, 
USA). IH11128 (075:K5:H–) is a mannose-resistant strain expressing both Dr and type 1 fimbriae but lack-
ing P fimbriae and hemolytic activity (provided by Bogdan Nowicki, University of  Texas, Galveston, Texas, 
USA). CFT073 (O6:H1:K2) expresses both type 1 and P fimbriae (provided by Sivaramesh Wigneshweraraj, 
Imperial College, London, UK).
1 3insight.jci.org   https://doi.org/10.1172/jci.insight.97626
R E S E A R C H  A R T I C L E
Induction of  pyelonephritis. Murine UTI, a model of  ascending UTI leading to pyelonephritis, was 
induced in female mice by bladder inoculation with UPEC (2 × 108 CFU in 50 μl PBS) via urethra as pre-
viously described (28, 29). Mice were killed at different time points (up to 72 hpi) for evaluation of  renal 
histopathology and bacterial load. In some experiments, mice were treated with C5aR1 peptide antagonist 
(PMX53) (35) or control peptide (1 mg/kg), at 2 hours before and 24 hours after inoculation by intraperi-
toneal (i.p.) injection.
Measurement of  bacterial load in the kidney. Total bacterial load in kidney tissue was measured by bacterial 
plate count assay as previously described, with modifications (19, 39). In brief, the tissue was homogenized 
in 2 ml (for the kidney) of  sterile PBS. Fifty microliters of  a serial dilution of  homogenates was plated on 
duplicate CLED plates. After incubation of  plates for 24 hours at 37°C, bacterial CFU on the plates were 
manually counted and expressed as an average CFU per gram of  kidney tissue.
Assessment of  kidney histopathology. Kidneys were fixed in a solution of  4% formalin in PBS for 24 hours 
and embedded in paraffin. Paraffin sections (3 μm) were stained with periodic acid–Schiff  (PAS) or hema-
toxylin and eosin (H&E). The severity of  renal histopathology (i.e., tissue destruction, cellular infiltration, 
bacterial patchiness, and presence of  abscesses), was graded using a 7-point scale as described previously 
with modifications (27, 40), in which 0, 1, 2, and 3 indicated normal, mild, moderate, and severe pyelone-
phritis, respectively (pathological changes were mainly located within the cortical-medullar junction and 
the medulla); while 4, 5, and 6 indicated mild, moderate, and severe pyelonephritis, respectively (pathologi-
cal changes spread to more parts of  the kidney). The assessment was performed in a blinded fashion by 2 
persons. Two to 3 kidney sections of  each mouse were viewed and are presented as an average score.
Lectin staining in kidney tissue. Frozen sections of  kidney were stained with fluorescein-labeled lectin 
(GNL or LCA and SNA) (20 μg/ml in PBS) and DAPI, and then viewed and imaged with a confocal laser 
scanning microscope system (Leica TCS SP8). The percentage of  positive staining area in each image 
under ×200 magnification was calculated by using ImageJ software v1.41 (NIH). Three to 4 viewing fields 
at the cortical-medullar junction for each kidney were examined.
Assessment of  bacterial colonization in kidney tissue. Overnight cultures of  UPEC strains were washed and 
then suspended in PBS (109 CFU/ml). TRITC was added to a final concentration of  1 mg/ml and incubated 
for 3 hours with gentle shaking in the dark. Bacteria were vigorously washed to remove unbound TRITC. 
For detection of  bacterial colonization in kidney tissues, TRITC-labeled E. coli J96 (2 × 108 CFU, in 50 μl 
PBS) were injected into the bladder via urethra. Mice were killed at 6 hpi, frozen sections of  infected kidney 
were stained with DAPI (for nuclei) and LTL (for proximal tubular cells), and then viewed and imaged 
with the Leica SP8 system. Bacterial colonies were manually counted at ×200 magnification and results are 
expressed as number of  colonies per field. Six to 10 viewing fields, randomly selected from inner medullar, 
cortical-medullar junction, and outer cortex (2–4 fields for each area) for each kidney were examined.
UPEC in situ binding to kidney tissue. Frozen sections (4 μm) of  OCT-embedded kidneys were immo-
bilized on Superfrost Plus microscope slides (Thermo Fisher Scientific) and were rehydrated in PBS for 
5 minutes and incubated with medium containing 0.1% BSA for 1 hour, and then with TRITC-labeled 
UPECs (2 × 108 CFU, in 200 μl of  PBS containing 0.1% BSA) for 1 hour at 37°C. Sections were then gently 
washed 5 times to remove unattached bacteria and stained with DAPI and fluorescein-labeled GNL, and 
then viewed and imaged with the Leica SP8 system. Bacterial colonies were manually counted at ×200 
magnification and results were expressed as number of  colonies per field. Five viewing fields at the cortical-
medullar junction for each kidney section were examined.
Assessment of  inflammatory cell infiltration in the kidney. Single renal cell suspensions were prepared using 
a method described previously, with modifications (19, 41). Kidneys were weighed, minced, and incubated 
with collagenase D (0.75 mg/ml) for 10 minutes at 37°C with gentle agitation. The collagenase was inac-
tivated with an equal volume of  DMEM-F12 containing 10% FCS. The digested tissue mixture was then 
passed through a 40-μm nylon sieve to remove tissue debris. The cell segments were collected and treated with 
RBC lysis buffer to remove remaining RBC. The cell pellet was washed and resuspended in PBS containing 
1% BSA and followed by flow cytometric analysis. The cells were preincubated with FcR-blocking antibody 
(CD16/32), then stained with rat anti–mouse APC-conjugated CD45, PE-conjugated Ly6G, PEcy7-conju-
gated Ly6C, and FITC-conjugated CD11b antibodies, or the appropriate isotype control antibodies at 4°C for 
20 minutes. In order to quantify absolute cell counts in kidney tissue, we used CountBright absolute counting 
beads in our flow cytometry assays, according to the manufacturer’s instructions. All flow cytometric analysis 
was performed using a FACSCalibur flow cytometer (BD Biosciences) and FlowJo software (Tree Star).
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Generation of  chimeric mice. Chimeric mice were generated using a method established in our laboratory 
(42). Mice were first irradiated with a dosage of  9 Gy and reconstituted with an intravenous administra-
tion of  7.5 × 106 donor bone marrow cells within 3 hours after irradiation. At 4 weeks after bone marrow 
transplantation, chimeric mice were used for induction of  pyelonephritis.
Cell cultures. Primary RTEC cultures were prepared from kidneys of  naive male WT or C5aR–/– mice as 
described previously (43). In brief, minced cortex and outer medulla was digested with 0.1% collagenase II 
and passed through a 40-μm nylon sieve. The cells and tubules were collected and cultured in DMEM-12 
medium that contained 2% FCS, insulin (5 μg/ml), transferrin (5 μg/ml), selenium (5 ng/ml), hydrocor-
tisone (40 ng/ml), and triiodothyronine (10–12 M). Non-passaged, 7- to 10-day-cultured RTECs were used 
for further experiments.
Assessment of  Man expression in cultured RTECs. Mannose residue expression in cultured RTECs was 
assessed by a fluorescence intensity–based microplate assay or fluorescence microscopic analysis. For 
microplate assay, confluent RTECs grown in 24-well plates were incubated with or without C5a and/or 
LPS for 24 hours at 37°C, and then with fluorescein-labeled GNL (20 μg/ml in PBS) for 1 hour at 37°C. 
Cells were then vigorously washed and lysed with sterile H2O. The fluorescence in the lysate was measured 
using a fluorescence plate reader (SpectraMax i3, Molecular Devices) with an excitation wavelength of  
490 nm and results expressed as relative fluorescence units. Fluorescence microscopic analysis was used 
to detect surface Man on RTECs. RTECs grown on the coverslips were pretreated with C5a and/or LPS 
and stained with fluorescein-labeled GNL and DAPI. Images were taken with the Leica SP8 system under 
×630 magnification. The percentage of  positive staining area in each image was calculated by using ImageJ 
software v1.41. Three to 4 viewing fields randomly selected from each coverslip were examined.
Assessment of  bacterial adhesion to cultured RTECs by fluorescence microscopy. RTEC monolayers grown on cov-
erslips in 24-well plates were incubated with TRITC-conjugated J96 (1 × 107 CFU/well) for 1 hour at 37°C. 
Cells were vigorously washed to remove unattached bacteria and stained with DAPI and fluorescein-labeled 
GNL, and then viewed and imaged with the Leica SP8 system. Bound bacteria and RTEC numbers were 
counted at ×630 magnification, and results are expressed as number of  bacteria per 103 tubule cells. Two to 
3 viewing fields randomly selected from each coverslip were examined and the average number is presented.
Assessment of  bacterial binding in RTECs by bacterial plate count assay. The assays were performed as 
described previously (44). Briefly, confluent RTEC monolayers were incubated with J96 (2 × 106 or 1 × 107 
CFU/well) for 1 hour at 37°C. Cells were then vigorously washed to remove unattached bacteria and lysed 
with sterile H2O. The lysate was then plated out on cysteine-, lactose-, and electrolyte-deficient (CLED) 
agar plates and incubated at 37°C for 24 hours. In some experiments, RTEC monolayers were preincubated 
with or without C5a for 24 hours and subjected to binding assay. Colonies were counted and results are 
expressed as CFU/gram of  cell protein. RTEC protein concentrations were measured using the Coomassie 
(Bradford) protein assay kit according to the manufacturer’s instructions.
RT-qPCR. Total RNA extraction from kidney tissue and cells and reverse transcription reactions were 
performed as previously described (45). RT-qPCR was performed using the DyNAmo HS SYBR Green 
qPCR kit from Thermo Fisher Scientific and an MJ Research PTC-200 Peltier Thermal Cycler from Bio-
Rad. Amplification was performed according to the manufacturer’s cycling protocol and tested in duplicate. 
The relative gene expression was analyzed using the 2–ΔΔCT method (46) and expressed as 2–ΔΔ (Ct), where Ct 
is cycle threshold, ΔΔ (Ct) = test samples Δ (Ct) – control sample Δ (Ct); Δ (Ct) = test gene (Ct) – 18S (Ct). 
The control samples were either normal kidney tissues or untreated cells. The test samples were infected 
kidney tissues or treated cells. The information for primer sequences is given in Supplemental Table 1.
ELISA. Renal cytokine levels were measured in the supernatant of  the kidney homogenates by ELISA, 
using ELISA kits for CXCL1 and TNF-α, according to the manufacturer’s instructions. For preparation 
of  kidney homogenates, individual kidneys were weighed and homogenized in PBS containing 1% Triton 
X-100, 1 mM EDTA, and 1% protease inhibitor cocktail and then spun clear at 10,000 g for 10 minutes 
as previously described (47). The resulting supernatants were analyzed by ELISA. Mouse C5a levels were 
measured in urine and kidney homogenates using paired ELISA antibodies for C5a. All test samples were 
measured in triplicate.
Statistics. Data are shown as the mean ± SEM or the readout of  individual mice. Mann-Whitney test 
(for CFU) or unpaired Student’s t test was used to compare the means of  2 groups. One-way or 2-way 
ANOVA was used to compare the means of  more than 2 independent groups. All the analyses were per-
formed using GraphPad Prism 7 software. P less than 0.05 was considered to be significant.
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Study approval. At King’s College London, animal experiments were performed in accordance with 
the Animals (Scientific Procedures) Act of  1986, UK, under a project licence (PPL707854) approved 
by Home Office, UK. At Xi’an Jiaotong University, animal experiments were performed according to 
protocols approved by the school Ethics Review Committee for Animal Experimentation.
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